Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
Messoud AshinaMichel Lanteri-MinetAnders EttrupCecilie Laurberg ChristoffersenMette Krog JosiassenRavinder PhulBjørn SperlingPatricia Pozo-RosichPublished in: Cephalalgia : an international journal of headache (2023)
ClinicalTrials.gov (Identifier: NCT04418765).